A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive
Clinical trial NCT03506399 · WITHDRAWN
Trial details
- NCT number
- NCT03506399
- Sponsor
- Eli Lilly and Company
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2018-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.